Search research articles
Contact Us
Filters
Showing results (121-130 of 168) with videos related to
Page
of 17
Sort By:
BMC Urology
|
August 7, 2019
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
Kerri Beckmann, Netty Kinsella, Henrik Olsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study
Voralak Vichapat, Hans Garmo, Marit Holmqvist, et al.
Scandinavian Journal of Urology
|
May 13, 2022
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Tiago M Bonde, Marcus Westerberg, Markus Aly, et al.
European Radiology
|
April 12, 2023
Magnetic resonance imaging of the knee for chronological age estimation-a systematic review
Lil-Sofie Ording Muller, Jan Adolfsson, Lisa Forsberg, et al.
The Lancet. Oncology
|
April 17, 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
Mieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Ecancermedicalscience
|
February 20, 2018
A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
Danielle Crawley, Florence Chamberlain, Hans Garmo, et al.
BJU International
|
January 15, 2019
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson, Hans Garmo, Mieke Van Hemelrijck, et al.
Frontiers in Oncology
|
November 2, 2020
Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
Jonathan Parker, Danielle Crawley, Hans Garmo, et al.
European Urology
|
July 17, 2017
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
Frederik Birkebæk Thomsen, Fredrik Sandin, Hans Garmo, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 168) with videos related to
Sort By:
Page
of 17
BMC Urology
|
August 7, 2019
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
Kerri Beckmann, Netty Kinsella, Henrik Olsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study
Voralak Vichapat, Hans Garmo, Marit Holmqvist, et al.
Scandinavian Journal of Urology
|
May 13, 2022
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Tiago M Bonde, Marcus Westerberg, Markus Aly, et al.
European Radiology
|
April 12, 2023
Magnetic resonance imaging of the knee for chronological age estimation-a systematic review
Lil-Sofie Ording Muller, Jan Adolfsson, Lisa Forsberg, et al.
The Lancet. Oncology
|
April 17, 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
Mieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Ecancermedicalscience
|
February 20, 2018
A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
Danielle Crawley, Florence Chamberlain, Hans Garmo, et al.
BJU International
|
January 15, 2019
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson, Hans Garmo, Mieke Van Hemelrijck, et al.
Frontiers in Oncology
|
November 2, 2020
Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
Jonathan Parker, Danielle Crawley, Hans Garmo, et al.
European Urology
|
July 17, 2017
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
Frederik Birkebæk Thomsen, Fredrik Sandin, Hans Garmo, et al.
Page
of 17